PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsLa Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company(LJPC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Angiotensin ii
hypertension
Calcium dobesilate
recurrence
,
large b-cell lymphoma diffuse
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
t-cell leukemia
,
b-cell leukemia
Aldosterone
healthy volunteers/patients
,
hyperkalemia
,
breast neoplasms
,
hypertension
,
hyperaldosteronism
,
heart failure
,
atrial fibrillation
Aspartame
healthy volunteers/patients
,
colorectal neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
sickle cell anemia
,
knee osteoarthritis
,
osteoarthritis
,
heart failure
,
lung neoplasms
,
ovarian neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
laryngeal neoplasms
,
opioid-related disorders
,
covid-19
,
coronavirus infections
,
carcinoma
,
neoplasms
,
brain neoplasms
,
glioma
,
neurofibromatosis 2
,
acoustic neuroma
,
meningioma
,
ependymoma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
neurilemmoma
,
body weight
,
cystic fibrosis
,
melanoma
,
biliary tract neoplasms
,
rare diseases
,
urinary bladder neoplasms
,
invasive hydatidiform mole
,
non-muscle invasive bladder neoplasms
,
non-hodgkin lymphoma
,
b-cell chronic lymphocytic leukemia
,
mantle-cell lymphoma
,
b-cell lymphoma
,
b-cell leukemia
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
obesity
,
non-small-cell lung carcinoma
,
asthma
,
pulmonary eosinophilia
,
overweight
,
weight loss
,
hyperkalemia
,
nasal polyps
,
endometrial neoplasms
,
borderline personality disorder
,
personality disorders
,
churg-strauss syndrome
,
eosinophilic granuloma
,
type 2 diabetes mellitus
,
breast neoplasms
,
fibrosis
,
inflammation
,
myocarditis
,
endomyocardial fibrosis
,
postoperative pain
,
depression
,
major depressive disorder
,
depressive disorder
,
systemic lupus erythematosus
Bevifimod
pharmacokinetics
,
sclerosis
,
neutropenia
,
neoplasms
,
amyotrophic lateral sclerosis
,
glioblastoma
,
myelodysplastic syndromes
,
crohn disease
,
eosinophilia
,
pulmonary eosinophilia
,
pituitary dwarfism
,
laron syndrome
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
healthy volunteers/patients
,
postmenopausal osteoporosis
,
optic neuritis
,
chronic urticaria
,
relapsing-remitting multiple sclerosis
,
multiple sclerosis
,
parkinson disease
,
treatment-resistant depressive disorder
,
medication adherence
,
inflammation
Hepcidin
anemia
Bos taurus adrenal cortex corticosteroids
macular degeneration
,
multiple myeloma
,
plasma cell neoplasms
,
systemic lupus erythematosus
,
castleman disease
,
myositis
,
geographic atrophy
,
prostatic neoplasms
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
castration-resistant prostatic neoplasms
,
breast neoplasms
Crystalloid
merkel cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use